Faculty

Back to Index
David Alan Ginsberg, MD
Associate Professor of Clinical Urology
Urology
NOR 7416 Health Sciences Campus Los Angeles
+1 323 865 3700

Overview

David Alan Ginsberg, MD is a native Southern Californian who earned his bachelor’s degree at the University of California at Berkeley. He subsequently returned to Los Angeles where he completed medical school and urology residency at the Keck School of Medicine of USC and its affiliated hospital, Los Angeles County Medical Center. Dr. Ginsberg finished his training at UCLA where he completed a fellowship focused on female urology, voiding dysfunction and urologic reconstruction.

Dr. Ginsberg is board certified in Urology and Female Pelvic Medicine & Reconstructive Urology and is also a Fellow of the American College of Surgeons. In addition to his faculty appointment at USC, Dr. Ginsberg is Chief of Urology at Rancho Los Amigo National Rehabilitation Center. Dr. Ginsberg’s clinical practice is focused on female pelvic medicine, which includes urinary incontinence and pelvic organ prolapse, neurogenic bladder and male voiding dysfunction.

Dr. Ginsberg’s present research interests focus on lower urinary tract reconstruction in spinal cord injury patients, urologic applications of botulinum toxin and long-term follow-up issues for patients with neurogenic bladder. Dr. Ginsberg is the author or co-author of over 70 peer-reviewed articles, numerous book chapters and is a regular reviewer for journals such as Journal of Urology, Urology, Neurourology & Urodynamics and Neurosurgery. He has held several visiting professorships and has been invited to lecture on multiple occasions throughout the United States and the world. He is on the urological editorial board for Medscape and was a member of the American Urological Association/American Board of Urology Exam Committee. Dr. Ginsberg is a present member of the American Urological Association Stress Incontinence Guidelines Panel.

Publications

Ginsberg DA. OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro. J Urol. 2016 Oct 11. View in: PubMed

Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3. 5-Year Study. J Urol. 2016 Sep; 196(3):791-800. View in: PubMed

McCoy O, Vaughan T, Nickles SW, Ashley M, MacLachlan LS, Ginsberg D, Rovner E. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal. J Urol. 2016 Aug; 196(2):484-9. View in: PubMed

Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 May; 91:46-51. View in: PubMed

Satkunasivam R, Santomauro M, Chopra S, Plotner E, Cai J, Miranda G, Salibian S, Aron M, Ginsberg D, Daneshmand S, Desai M, Gill IS. Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life. Eur Urol. 2016 Feb; 69(2):247-53. View in: PubMed

Freemantle N, Ginsberg DA, McCool R, Fleetwood K, Arber M, Khalaf K, Loveman C, Ni Q, Glanville J. Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison. BMJ Open. 2016; 6(2):e009122. View in: PubMed

Vainrib M, Reyblat P, Ginsberg D. Outcomes of Male Sling Mesh Kit Placement in Patients with Neuropathic Stress Urinary Incontinence: A Single Institution Experience. Urol Int. 2015 Dec; 95(4):406-10. View in: PubMed

Ginsberg DA, Schneider LK, Watanabe TK. Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies. Arch Phys Med Rehabil. 2015 Sep; 96(9 Suppl):S341-S357. e1. View in: PubMed

Ginsberg DA. Editorial comment. J Urol. 2015 Jun; 193(6):2094. View in: PubMed

Goldmark E, Niver B, Ginsberg DA. Neurogenic bladder: from diagnosis to management. Curr Urol Rep. 2014 Oct; 15(10):448. View in: PubMed

Vainrib M, Reyblat P, Ginsberg DA. Long-term Efficacy of Repeat Incisions of Bladder Neck/External Sphincter in Patients With Spinal Cord Injury. Urology. 2014 Oct; 84(4):940-5. View in: PubMed

Danforth TL, Ginsberg DA. Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics? Urol Clin North Am. 2014 Aug; 41(3):445-52, ix. View in: PubMed

Danforth TL, Aron M, Ginsberg DA. Robotic sacrocolpopexy. Indian J Urol. 2014 Jul; 30(3):318-25. View in: PubMed

Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, Ginsberg D. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int. 2014 Mar; 113(3):484-91. View in: PubMed

Ginsberg D, Cruz F, Herschorn S, Gousse A, Keppenne V, Aliotta P, Sievert KD, Brin MF, Jenkins B, Thompson C, Lam W, Heesakkers J, Haag-Molkenteller C. OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor activity regardless of concomitant anticholinergic use or neurologic etiology. Adv Ther. 2013 Sep; 30(9):819-33. View in: PubMed

Vainrib M, Simma-Chiang V, Boyd SD, Ginsberg DA. Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion. Neurourol Urodyn. 2013 Sep; 32(7):1010-3. View in: PubMed

Ginsberg D, Schneider T, Kelleher C, Van Kerrebroeck P, Swift S, Creanga D, Martire DL. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder. BJU Int. 2013 Aug; 112(3):373-85. View in: PubMed

Ginsberg D. Optimizing therapy and management of neurogenic bladder. Am J Manag Care. 2013 Jul; 19(10 Suppl):s197-204. View in: PubMed

Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care. 2013 Jul; 19(10 Suppl):s191-6. View in: PubMed

Vainrib M, Reyblat P, Ginsberg DA. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Neurourol Urodyn. 2013 Mar; 32(3):250-3. View in: PubMed

Ginsberg DA. Editorial comment. Urology. 2012 Aug; 80(2):464-5. View in: PubMed

Fowler CJ, Auerbach S, Ginsberg D, Hale D, Radziszewski P, Rechberger T, Patel VD, Zhou J, Thompson C, Kowalski JW. OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial. Eur Urol. 2012 Jul; 62(1):148-57. View in: PubMed

Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Brin MF, Jenkins B, Haag-Molkenteller C. Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity. J Urol. 2012 Jun; 187(6):2131-9. View in: PubMed

Simma-Chiang V, Ginsberg DA, Teruya KK, Boyd SD. Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the university of southern california experience. Urology. 2012 Jun; 79(6):1397-401. View in: PubMed

Ginsberg DA. Bladder acontractility: detrusor myoplasty and other options. Nat Rev Urol. 2011 Apr; 8(4):185-6. View in: PubMed

Ginsberg DA, Oefelein MG, Ellsworth PI. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials. Neurourol Urodyn. 2011 Apr; 30(4):563-7. View in: PubMed

MacDiarmid SA, Ellsworth PI, Ginsberg DA, Oefelein MG, Sussman DO. Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder. Urology. 2011 Jan; 77(1):24-9. View in: PubMed

Reyblat P, Ginsberg DA. Augmentation enterocystoplasty in overactive bladder: is there still a role? Curr Urol Rep. 2010 Nov; 11(6):432-9. View in: PubMed

Ginsberg DA. Indications and complications of cystectomy in patients with neurogenic bladder. J Urol. 2010 Jul; 184(1):10-1. View in: PubMed

Reyblat P, Ginsberg DA. Editorial comment. Urology. 2010 Jun; 75(6):1308-9; author reply 1309. View in: PubMed

Ginsberg DA. Editorial comment. Urology. 2009 Oct; 74(4):775; author reply 776-7. View in: PubMed

Reyblat P, Chan KG, Josephson DY, Stein JP, Freeman JA, Grossfeld GD, Esrig D, Ginsberg DA. Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients. World J Urol. 2009 Feb; 27(1):63-8. View in: PubMed

Reyblat P, Ginsberg DA. Augmentation cystoplasty: what are the indications? Curr Urol Rep. 2008 Nov; 9(6):452-8. View in: PubMed

Yang J, Liu L, Xie HW, Ginsberg DA. Chinese urologists' practice patterns of diagnosing and treating chronic prostatitis: a questionnaire survey. Urology. 2008 Sep; 72(3):548-51. View in: PubMed

Liu LF, Yang JR, Ginsberg DA, Xie HW, Rao JM, Wang L, Yin Z, He Q, Yang TB. Factors influencing the diagnosis and treatment of chronic prostatitis among urologists in China. Asian J Androl. 2008 Jul; 10(4):675-81. View in: PubMed

Ginsberg DA, Phillips SE, Wallace J, Josephson KL. Evaluating and managing constipation in the elderly. Urol Nurs. 2007 Jun; 27(3):191-200, 212; quiz 201. View in: PubMed

Ginsberg DA. Management of the neurogenic bladder in the female patient. Curr Urol Rep. 2006 Sep; 7(5):423-8. View in: PubMed

Quek ML, Barry P, Stein JP, Lieskovsky G, Ginsberg DA. Combined radical prostatectomy and bladder augmentation for concomitant prostate cancer and detrusor instability. Urology. 2005 May; 65(5):964-7. View in: PubMed

Shpall AI, Ginsberg DA. Bladder neck closure with lower urinary tract reconstruction: technique and long-term followup. J Urol. 2004 Dec; 172(6 Pt 1):2296-9. View in: PubMed

Wilson S, Quek ML, Ginsberg DA. Transurethral injection of bulking agents for stress urinary incontinence following orthotopic neobladder reconstruction in women. J Urol. 2004 Jul; 172(1):244-6. View in: PubMed

Quek ML, Ginsberg DA, Wilson S, Skinner EC, Stein JP, Skinner DG. Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. J Urol. 2004 Jul; 172(1):219-21. View in: PubMed

Tabibian L, Ginsberg DA. Thrombosed urethral hemangioma. J Urol. 2003 Nov; 170(5):1942. View in: PubMed

Ginsberg DA. Vaginal vault prolapse: evaluation and repair. Curr Urol Rep. 2003 Oct; 4(5):404-8. View in: PubMed

Zommick JN, Simoneau AR, Skinner DG, Ginsberg DA. Continent lower urinary tract reconstruction in the cervical spinal cord injured population. J Urol. 2003 Jun; 169(6):2184-7. View in: PubMed

Shpall AI, Varpetian A, Ginsberg DA. Urinary retention in a patient with West Nile virus. Urology. 2003 Jun; 61(6):1259. View in: PubMed

Daneshmand S, Ginsberg DA, Bennet JK, Foote J, Killorin W, Rozas KP, Green BG. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol. 2003 Jan; 169(1):199-202. View in: PubMed

Quek ML, Ginsberg DA. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol. 2003 Jan; 169(1):195-8. View in: PubMed

Stein JP, Ginsberg DA, Skinner DG. Indications and technique of the orthotopic neobladder in women. Urol Clin North Am. 2002 Aug; 29(3):725-34, xi. View in: PubMed

Ginsberg DA, Boyd SD. Permanent urinary retention after transurethral injection of collagen. J Urol. 2002 Feb; 167(2 Pt 1):648. View in: PubMed

Powered bySC CTSI